Recent News

By Category: Agents & Toxins

Possible epidemic: Cattle at risk as foot-and-mouth disease on the rise

(The Express Tribune) Tribesmen in the agency said the disease has spread in Mishti, Firozkhel, Utmankhel, Sheikhan and Anjghali in the last couple of weeks while they have no arrangements to treat it. Malik Shah Muhammad, a resident of Firozkhel, said their cattle starts spitting out saliva mixed with blood from their mouth and die  Read More »

Biosecurity vital in combating swine virus in N.D.

(Farm and Ranch) Implementing strict biosecurity procedures is as important as ever, now that North Dakota has its first case of the porcine epidemic diarrhea virus (PEDv), North Dakota State University Extension Service swine specialist David Newman says. The PEDv has killed more than 4 million U.S. pigs since it was discovered in the country  Read More »

BioCryst Announces Nature Publication Demonstrating Efficacy of BCX4430 in a Non-Human Primate Model of Filovirus Infection

(MarketWatch) BioCryst Pharmaceuticals, Inc. BCRX today announced the online publication in the journal Nature of extensive laboratory and nonclinical characterizations of BCX4430, including efficacy results in animal models of infection with Marburg virus and Ebola virus, two highly virulent pathogens responsible for viral hemorrhagic fever diseases. The Nature online publication, “Protection against filovirus diseases by  Read More »

Pharma refuses to ensure access to lifesaving Hepatitis C treatment at global meeting

(Medical News Today) Thirty-eight activists from 22 countries joined forces at the first-ever Hepatitis C Virus (HCV) World Community Advisory Board (CAB) to demand equitable access to treatment for hepatitis C virus (HCV) from six multinational pharmaceutical companies. Yet AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Merck, and Roche refused to provide a plan for equitable access  Read More »

Deadly Immune ‘Storm’ Caused by Emergent Flu Infections

(Global Biodefense) Scientists at The Scripps Research Institute (TSRI) have mapped key elements of a severe immune overreaction—a “cytokine storm”—that can both sicken and kill patients who are infected with certain strains of flu virus. Their findings also clarify the workings of a potent new class of anti-inflammatory compounds that prevent this immune overreaction in  Read More »